“an increasing trend”

Results Morbidity and incidence-based mortality of CHC between 2004 and 2015 The overall incidence of CHC seemed to have an increasing trend with a borderline P value (P=0.060).

4 B, Pearson’s correlation = 0.51, p = 0.061), and an increasing trend in the percent CD4+ CD45RA+ naïve T-cells post-supplement (Fig. 4 C, Pearson’s correlation = 0.50, p = 0.060), and a significantly lower CD4+ CD45RO+: CD4+ CD45RA+ T-cell ratio after supplementation (Fig. 4 D, Pearson’s correlation = 0.67, p = 0.008).

The activity of xanthine oxidase exhibited an increasing trend in the liver of the fructose-fed female rats in comparison with the control group ( P = 0.06), while it remained unaltered in the VAT after fructose diet ( Figure 3G ).

Coated cysteamine supplementation showed an increasing trend in villus height ( p = 0.060), villus height/crypt depth (V/C) ( p = 0.056), the expression levels of zonula occludens-1 (ZO-1) mRNA ( p = 0.061), and Occludin mRNA ( p = 0.074) in the jejunum.

In acute appendicitis, DTO showed an increasing trend from 181.2 (± 66.6) min to 208.9 (± 137.3) min without statistical significance ( P =0.06) whereas hospital stay decreased from 3.5 (± 3.5) days to 3.1 (± 1.9) days ( P =0.33) which was not statistically significant.

The CSS at 5 years showed an increasing trend in node negativity cohort compared to node positivity cohort (98% vs 90%; P = .06).

Muscle tissue (samples taken at rest prior to exercise) showed an increasing trend (~1.5‐fold) in terms of baseline ADP‐stimulated mitochondrial respiration in permeabilized fibers ( n = 6; P = 0.06; Table 1 ).

Before NSBB introduction, SVR (1896 to 1348 dyn·s·cm −5 ; p = 0.028) and PVR (47 to 30 mmHg·min·dl·ml −1 ; p = 0.04) significantly decreased after LVP, while CO showed an increasing trend (3.9 to 4.5 l/m; p = 0.06).

As shown in Figure 4 A, mitochondrial NADH dehydrogenase 1, complex I ( Nd1 ), mitochondrial NADH dehydrogenase 5, complex 1 ( Nd5 ), cytochrome b, complex III ( Cytb ), mitochondrial cytochrome c oxidase I, complex IV ( Cox1 ), and mitochondrial ATP synthase 6, complex V ( Atp6 ) all showed an increasing trend (i.e., Nd1 and Atp6 , P = 0.06), with significant increases in Cytb ( P = 0.04) and Cox1 ( P = 0.04).

The individual RRs for natural background level of expo- sure exhibited an increasing trend (RRs = 1.00, 1.03, and 1.55; p = 0.06).

Cognitive function showed an increasing trend across CNQ tertiles, from 12.89 in the lowest group to 14.37 in the highest ( P = 0.06), although the difference did not reach statistical significance.

Although EE digestibility was reduced by fructose treatment, the relative gene expression of fatty acid transporter protein 4 ( FATP ) showed an increasing trend ( P = 0.060, Fig. 3 F).

An increasing trend of Aβ 1–42 /Aβ 1–40 ratio was observed in VGs 0.005 (CI: −0.001, 0.010, p = 0.06) compared to RMEs, however was not statistically significant. p-tau181 Plasma p-tau181 was significantly higher in the LOV group compared to RMEs (p < 0.01) ( Figure 1(b) ). p-tau181 was not found to be statistically significantly different between other PBDs and RME.

Although an increasing trend was observed, the overall difference among the subgroups was not statistically significant ( p = 0.06).

SV was initially reduced at week 2 (33±3 versus 29±4 μL), and an increasing trend was observed at week 4 ( P =0.06).

Responding patients displayed an increasing trend of this parameter at T1, which was not statistically significant (p=0.06, Figure 5B ).

Although there was an increasing trend over the months, as per the results from the descriptive analysis, our result from the trend test shows an insignificant (p-value = 0.06) change in trend.

However, only an increasing trend ( p = 0.06) in IL-6 gene expression was observed in liver PBA samples compared to control at d 15 ( Table 9 ).

GSH-Px activity exhibited an increasing trend at both MGE inclusion levels (p = 0.06) ( Figure 1d ).

Rosiglitazone treatment had no effect upon PPAR- γ protein, while SIRT1 protein was increased under 1% oxygen with Rosiglitazone ( Figure 6(f) ) and UCP-2 protein displayed an increasing trend ( P < .06).

The sum of power recorded from all electrodes was not altered significantly by celecoxib treatment, while it showed an increasing trend in the celecoxib group, especially at 4 hours after initial administration ( p = 0.06).

When challenged with subtherapeutic concentrations of cefotaxime, the conjugation frequencies showed an increasing trend ( p = 0.06), with increasing concentrations of CTX when calculated based on donor count.

In the liver, total cholesterol was lower ( p = 0.046), and triglycerides were higher ( p = 0.04) in the HS birds, whereas the expression of SREBP-1c showed an increasing trend ( p = 0.06).

3.4.2 Fatty acid content of LD As presented in Table 2 , compared with CON, the levels of decanoic acid (C10:0) (P < 0.05), myristic acid (C14:0) ( P < 0.05), myristoleic acid (C14:1) ( P < 0.05), palmitoleic acid (C16:1) ( P < 0.01), and α-linolenic acid (ALA) ( P < 0.05) in LD were increased significantly in 25% ALM diet, and the content of monounsaturated fatty acid (MUFA) showed an increasing trend ( P = 0.06).

Growth Performance Compared with CON, the ADG of the TAN group showed an increasing trend both in the d 0 to 30 ( p = 0.06) and d 31 to 65 ( p = 0.07) of the in vivo experiment.